🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

"I've benefitted in my own lab from having a diverse lab of coworkers." To mark International Day of Women and Girls in Science, watch laureates Andrea Ghez and Carolyn Bertozzi (Carolyn Bertozzi) speak about the importance of diversity. #WomenInScience

Protect Biomedical Research and Innovation congressweb.com/AIMBE/4?framed… #

SITC is deeply concerned by the announcement from NIH that will cut billions of dollars in indirect costs. We urge the NIH & the new administration to reverse this action to ensure life-saving cancer treatments continue to reach the clinic and patients. sitcancer.org/advocacy/indir…

Pitt to pause PhD admissions, following Vanderbilt and USC, because of uncertainty of NIH funding to academic universities. Who will teach and train US scientists for pharma and biotech? Should we import them from countries that do? wesa.fm/health-science…

Francis Collins resigned from NIH yesterday. He rightly pointed out that it's Human Genome Project revolutionized every aspect of biomedical research. He points out that NIH has historically been sens as high priority and non partisan. 1/

Updated lab photo! Today we celebrated postdoctoral fellow Kazuki Sone, whose last day in the lab is tomorrow, before he heads to Japan for a Chief Researcher position. Thank you Kazuki for being a fantastic scientist and labmate, and congratulations on your new role!

Congratulations Dr. Nina Bhardwaj !

Congratulations to Dr. Nina Bhardwaj on being named a Fellow of the AACR Academy Class of 2025. Bhardwaj Lab

Congratulations to several members of our Vaccine and Cell Therapy Laboratory, past and present, on the publication of our PGV neoantigen vaccine trial data in Cancer Discovery! 🥳

Personalized cancer vaccine proves promising in a phase 1 trial medicalxpress.com/news/2025-03-p… via Medical Xpress Bhardwaj Lab Icahn School of Medicine at Mount Sinai

Grateful to the The GOG Foundation Inc. for the opportunity to present our research at fellows forum and honored to receive the best overall presentation award! Stephanie Blank Bhardwaj Lab Matthew Brown Icahn School of Medicine at Mount Sinai The Tisch Cancer Institute

Belated post: last month we said goodbye to Jenna Newman, Ph.D., who was a postdoctoral fellow in the lab for 5 years. Congratulations on your exciting new journey as a Senior Scientist at AstraZeneca! You’ve been a fantastic member of our lab in so many ways & we miss you already!

We tested the feasibility and immunogenicity of a personalized neoantigen vaccine + PD-L1 blockade in #bladdercancer including the adjuvant setting. nature.com/articles/s4301… Jon Anker, MD, PhD Bhardwaj Lab UroToday.com Uromigos The Tisch Cancer Institute Dr. Bishoy M. Faltas Nature Cancer Bladder Cancer Advocacy Network

See our study in Nature Cancer evaluating personalized neoantigen vaccine + atezo in urothelial cancer First report in the adjuvant setting for UC, randomized phase 2s ongoing Matt Galsky Bhardwaj Lab The Tisch Cancer Institute Uromigos Bladder Cancer Advocacy Network UroToday.com nature.com/articles/s4301…

Results from a phase 1 study led by Drs. Nina Bhardwaj and Matt Galsky show that their custom-made vaccine, in combination with immune checkpoint inhibitor, is safe and able to spark strong immune responses in people with #BladderCancer. Bhardwaj Lab The Tisch Cancer Institute Nature Cancer

Nina Bhardwaj, MD, PhD, is pleased to serve as Co-Chair of #CICON25. cancerimmunotherapyconference.org Registration is open now. Bhardwaj Lab

From the May issue: PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematological Malignancies in the Adjuvant Setting brnw.ch/21wSQPX

By Mansi Saxena, Tom Marron MD PHD, Philip Friedlander, alex rubinsteyn, Bhardwaj Lab and colleagues The Tisch Cancer Institute UNC-Chapel Hill

Atezolizumab in combination with personalized neoantigen vaccine for urothelial cancer. urotoday.com/recent-abstrac… via UroToday.com Bhardwaj Lab Matt Galsky Icahn School of Medicine at Mount Sinai #bladdercancer

Excited for #CICON25 this September in Utrecht, Netherlands🇳🇱! A leading international meeting focused on advancing cancer immunotherapy. U.S. researchers are strongly encouraged to participate! 🗓 Abstracts due June 1 🔗 cancerimmunotherapyconference.org